👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Trulieve Cannabis director Richard May buys shares worth $7,018

Published 21/11/2024, 23:10
TRUL
-

In a recent move, Richard S. May, a director at Trulieve Cannabis (OTC:TCNNF) Corp. (CSE:TRUL), acquired 1,160 subordinate voting shares of the company. The shares were purchased at a price of $6.05 each, totaling approximately $7,018. Following this acquisition, May now holds 551,036 shares directly.

This transaction, disclosed in a recent SEC filing, reflects May's continued investment in Trulieve Cannabis, a leading player in the medicinal chemicals and botanical products sector. The company, headquartered in Quincy, Florida, remains a significant entity in the cannabis industry.

InvestingPro Insights

Richard S. May's recent acquisition of Trulieve Cannabis Corp. shares comes at a time when the company faces several challenges, as highlighted by InvestingPro data and tips. The stock's price has experienced significant volatility, with a striking 99.9% decline over the past three months. This dramatic drop aligns with an InvestingPro Tip indicating that the stock "generally trades with high price volatility."

Despite May's show of confidence through his share purchase, InvestingPro Tips reveal that Trulieve "suffers from weak gross profit margins" and its "valuation implies a poor free cash flow yield." These factors may contribute to the company's recent stock performance and could be areas of concern for potential investors.

It's worth noting that Trulieve does not pay a dividend to shareholders, which might impact its attractiveness to income-focused investors. The company's average daily trading volume over the past three months stands at 0.07 million USD, reflecting relatively modest liquidity in the stock.

For a more comprehensive analysis, InvestingPro offers additional tips and insights that could provide valuable context to May's recent share acquisition and Trulieve's overall market position. Investors interested in a deeper dive into Trulieve's financial health and market performance can access more than 6 additional InvestingPro Tips.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.